ACTU - ACTUATE THERAPEUTICS, INC.
2.53
-0.250 -9.881%
Share volume: 202,247
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$2.78
-0.25
-0.09%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 09-24-2024 | 11-13-2024 | 03-13-2025 | 05-15-2025 | 11-13-2025 | 03-26-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 5.435 M | 5.393 M | 0.000 | 6.366 M | 5.472 M | 4.688 M | |
| Selling general and admin | 1.063 M | 1.636 M | 0.000 | 3.145 M | 3.294 M | 2.559 M | |
| Research and development | 4.373 M | 3.757 M | 0.000 | 3.220 M | 2.178 M | 2.130 M | |
| Total expenses | 5.435 M | 5.393 M | 0.000 | 6.366 M | 5.472 M | 4.688 M | |
| -0.78% | -100.00% | -14.03% | -14.32% | ||||
| Operating income | -5.435 M | -5.393 M | 0.000 | -6.366 M | -5.472 M | -4.688 M | |
| Ebit | -6.576 M | -6.048 M | 0.000 | -6.366 M | -5.472 M | -4.688 M | |
| Pretax income | -6.572 M | -5.971 M | 0.000 | -6.317 M | -5.407 M | -4.554 M | |
| -9.15% | -100.00% | -14.40% | -15.78% | ||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -6.572 M | -5.971 M | 0.000 | -6.317 M | -5.407 M | -4.554 M | |
| 9.15% | 100.00% | 14.40% | 15.78% |